Neogen reported $60.59M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agilent A:US $ 900M 48M
Atrion ATRI:US 17.79M 77K
Avanos Medical Inc AVNS:US $ 90.4M 4.7M
Bio Rad Laboratories BIO:US $ 441.56M 38.86M
Cerus CERS:US $ 24.52M 2.08M
Danaher DHR:US $ 4359M 38M
Idexx Laboratories IDXX:US $ 472.92M 16.39M
Illumina ILMN:US $ 770M 32M
Integra Lifesciences IART:US $ 248.25M 1.2M
Meridian Bioscience VIVO:US $ 44.72M 7.61M
Neogen NEOG:US $ 60.59M 0.59M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Pacific Biosciences Of California PACB:US $ 15.36M 1.61M
Quidel QDEL:US $ 373.41M 267.22M
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sientra SIEN:US 10.59M 675K
Staar Surgical STAA:US $ 45.3M 3.9M
Surmodics SRDX:US $ 19.81M 1.04M
Thermo Fisher Scientific TMO:US $ 4797M 273M
Zoetis ZTS:US $ 1408M 24M